MADRID, 6 de diciembre de 2023 /PRNewswire/ — Appian (Nasdaq: APPN) ha anunciado hoy que ha sido nombrada Líder en el nuevo informe The Forrester Wave™: Digital Process Automation Software, Q4 2023. En la evaluación de 26 criterios provenientes de 15 proveedores de automatización de procesos digitales (APD o DPA por sus siglas en inglés), Appian… Continue reading Appian nombrado líder en el informe de software de automatización de procesos digitales
Category: Newswire
UCLA Anderson Forecast Says, Despite Geopolitical Uncertainty, Data Indicate No Recession
California’s slower-growing economy continues to outpace the weak growth of the U.S. economy LOS ANGELES, Dec. 6, 2023 /PRNewswire/ — In its fourth and final economic forecast of 2023, the UCLA Anderson Forecast says that the threat of imminent recession has faded. This development results from expansionary fiscal policy, new national industrial policy and a… Continue reading UCLA Anderson Forecast Says, Despite Geopolitical Uncertainty, Data Indicate No Recession
Appian nommé leader dans le rapport sur les logiciels d’automatisation des processus numériques par un cabinet d’études indépendant
PARIS, 6 décembre 2023 /PRNewswire/ — Appian (Nasdaq : APPN) a annoncé aujourd’hui sa nomination en tant que leader dans le nouveau rapport, The Forrester Wave™ : Digital Process Automation Software, Q4 2023 . Dans l’évaluation basée sur 26 critères parmi 15 fournisseurs d’automatisation des processus numériques (APN), Appian a obtenu le meilleur score dans la… Continue reading Appian nommé leader dans le rapport sur les logiciels d’automatisation des processus numériques par un cabinet d’études indépendant
CME Group to Launch FX Spot+ to Connect OTC and Futures Liquidity
CHICAGO and LONDON, Dec. 6, 2023 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced that it will launch CME FX Spot+, a new, all-to-all spot FX marketplace that will connect cash market participants with the company’s FX futures liquidity. The offering is expected to be made available for client testing during the… Continue reading CME Group to Launch FX Spot+ to Connect OTC and Futures Liquidity
Appian als führender Anbieter von Software für digitale Prozessautomatisierung eingestuft
BERLIN, 6. Dezember 2023 /PRNewswire/ — Appian (Nasdaq: APPN) wird in der neuen Studie „The Forrester Wave™: Digital Process Automation Software, Q4 2023″, als „Leader” eingestuft. Von 15 Anbietern für digitale Prozessautomatisierung (DPA) erreichte Appian die höchste Platzierung im Bereich „Current Offering”. Bei der umfassenden Bewertung für diesen Bereich wurden 26 Kriterien berücksichtigt. Continue Reading In… Continue reading Appian als führender Anbieter von Software für digitale Prozessautomatisierung eingestuft
Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma
XPOVIO® (selinexor) is the first and only exportin 1 (XPO1) inhibitor approved in Macau. XPOVIO® has received regulatory approvals in 42 countries and regions including Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore and Australia. SHANGHAI AND HONG KONG, Dec. 6, 2023 /PRNewswire/ — Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a… Continue reading Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics
Premium vector technology will improve the production of high-yielding mammalian cell lines SAN DIEGO, Dec. 6, 2023 /PRNewswire/ — Abzena, the leading end-to-end bioconjugate and complex biologics CDMO has announced a partnership with ProteoNic Biosciences BV, to license their premium protein expression technology, 2G UNic®. This state-of-the-art vector technology will significantly improve the production of… Continue reading Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8%
JINAN, China, Dec. 6, 2023 /PRNewswire/ — Qilu Pharmaceutical presented the latest results of the single-arm, phase II pivotal clinical study for iparomlimab (QL1604), an innovative Class 1 antibody monotherapy used to treat unresectable or metastatic dMMR/MSI-H solid tumors through a poster presentation at the European Society for Medical Oncology Asia Congress 2023 (ESMO Asia)… Continue reading Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8%
poLight ASA To Showcase Tunable Optics Technology At SPIE Photonics West 2024
CTO Pierre Craen Presents and Company Will Demonstrate TLens® and TWedge® in Booth # 5336 HORTEN, Norway, Dec. 6, 2023 /PRNewswire/ — poLight ASA (OSE: PLT) announced that Chief Technology Officer Pierre Craen will present at the SPIE Photonics West 2024, the world’s premier event for optics and optoelectronics technology. His presentation, scheduled for January… Continue reading poLight ASA To Showcase Tunable Optics Technology At SPIE Photonics West 2024
TV360 Acquires Exclusive Broadcasting Rights For Euro 2024
HANOI, Vietnam, Dec. 6, 2023 /PRNewswire/ — Viettel Telecom, the leading telecommunications company in Vietnam, held an event to announce that TV360, its television streaming application, has obtained the official broadcasting rights for UEFA EURO 2024 – the European Championship. TV360 now holds the exclusive rights to broadcast and distribute the tournament across all television… Continue reading TV360 Acquires Exclusive Broadcasting Rights For Euro 2024